Answer
During selumetinib hydrogen sulfate (Koselugo) treatment, liver laboratory values should be monitored at least monthly during the first six months, as well as before treatment initiation and thereafter as clinically indicated.
Sources for this answer
- Koselugo 10 mg hard capsulesAstraZeneca UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked